- Trials with a EudraCT protocol (121)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
121 result(s) found for: Cardiac therapeutic procedures.
Displaying page 1 of 7.
| EudraCT Number: 2006-003053-24 | Sponsor Protocol Number: 614 | Start Date*: 2006-05-18 | |||||||||||
| Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
| Full Title: Prophylaxis with fenoldopam in cardiac surgery patients at high risk of postoperative renal failure | |||||||||||||
| Medical condition: cardiac surgery patients at high risk of postoperative renal failure | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-022679-71 | Sponsor Protocol Number: Xenon-MTH-Studie | Start Date*: 2011-01-07 | |||||||||||
| Sponsor Name:Clinical Trials Center Aachen, University of Aachen | |||||||||||||
| Full Title: Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation | |||||||||||||
| Medical condition: In this clinical trial will be checked, whether 2 hours ventilation with xenon has neuroprotetctive effect on the patients, which had out of hospital cardiac arrest and successful cardiopulmonary r... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-000177-39 | Sponsor Protocol Number: Linea7-2013/06-APPEAR | Start Date*: 2014-07-17 |
| Sponsor Name:IRCCS Policlinico San Donato | ||
| Full Title: Albumin vs. Plasma for PEdiAtric pRiming (APPEAR) trial | ||
| Medical condition: Congenital cardiac diseases needing surgical correction requiring intervention with extracorporeal circulation | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-000404-28 | Sponsor Protocol Number: CRAD001ANO05 | Start Date*: 2016-07-20 | |||||||||||
| Sponsor Name:Novartis Norge AS | |||||||||||||
| Full Title: 5, 6 or 7 year follow-up control after the SCHEDULE study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE) Title of the original SCHEDULE study: A controlled ran... | |||||||||||||
| Medical condition: Heart transplantation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-005920-16 | Sponsor Protocol Number: CHUB-930105 | Start Date*: 2012-02-06 |
| Sponsor Name:Association Hospitalière CHU Brugmann | ||
| Full Title: Prospective, controled, randomized, double blind monocentric study evaluating the efficacy of the basic component of colloids (corn versus potato) on perioperative blood losses in elective cardiac ... | ||
| Medical condition: Elective cardiac surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-002556-27 | Sponsor Protocol Number: ALBICS | Start Date*: 2016-11-25 | |||||||||||
| Sponsor Name:Helsinki University Hospital | |||||||||||||
| Full Title: Albumin in cardiac surgery | |||||||||||||
| Medical condition: Cardiac surgery with cardiopulmonary bypass operations. Elective and emergency patients. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-005440-98 | Sponsor Protocol Number: | Start Date*: 2012-04-12 | |||||||||||
| Sponsor Name:AKH Linz | |||||||||||||
| Full Title: Double blinded randomised trial for the evaluation of the effectiveness of prophylactic use of sildenafil for the prevention of pulmonary hypertensive crisis after congenital heart surgery | |||||||||||||
| Medical condition: Ventriculs septal defect, atrioventricular canal with pulmonary hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-000222-35 | Sponsor Protocol Number: 2017-000222-35 | Start Date*: 2017-07-21 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients – a randomized controlled trial | ||
| Medical condition: Secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis therapy. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-002510-23 | Sponsor Protocol Number: SR062014 | Start Date*: 2014-09-17 |
| Sponsor Name:University hospitals of Leuven | ||
| Full Title: as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: a randomized controlled clinical trial | ||
| Medical condition: Xenon anesthesia in children undergoing cardiac catheterization | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-003027-30 | Sponsor Protocol Number: IIBSP-ALB-2017-72 | Start Date*: 2017-11-27 |
| Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau | ||
| Full Title: Influence of albumin on the development of acute renal dysfunction associated with cardiac surgery under extracorporeal circulation | ||
| Medical condition: Renal function | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-002248-26 | Sponsor Protocol Number: IEOS701/412 | Start Date*: 2012-10-16 | |||||||||||
| Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
| Full Title: Prevention of anthracycline-induced cardiotoxicity: a multicentre randomizedtrial comparing two therapeutic strategies. | |||||||||||||
| Medical condition: Anthracycline-‐induced cardiotoxicity | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-003638-38 | Sponsor Protocol Number: FIM-SEV-2022-01 | Start Date*: 2023-04-10 | |||||||||||
| Sponsor Name:FIMABIS | |||||||||||||
| Full Title: CARDIOPROTECTIVE-NEPHROPROTECTIVE EFFECTS OF SEVOFLURAN IN COMPARISON WITH PROPOFOL IN DOUBLE VALVULAR SURGERY. USE OF SEVOFLURANE AS A PILLAR OF PROTECTION IN EXTRACORPOREA CIRCULATION AND POSTOPE... | |||||||||||||
| Medical condition: DOBLE VALVE SURGERY | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-003401-26 | Sponsor Protocol Number: 400-12-006 | Start Date*: 2014-05-16 |
| Sponsor Name:Ethicon Inc. | ||
| Full Title: A Prospective, Randomized, Controlled, Study Evaluating EVICEL® Fibrin Sealant as an Adjunct to Hemostasis During Abdominal, Retroperitoneal, Pelvic or Thoracic (Non‐Cardiac) Surgery in Pediatric P... | ||
| Medical condition: Abdominal, Retroperitoneal, Pelvic or Thoracic (Non‐Cardiac) Surgery | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-000401-76 | Sponsor Protocol Number: 7715 | Start Date*: 2019-11-26 |
| Sponsor Name:University hospital of Montpellier | ||
| Full Title: Transfusion savings in heart surgery: impact of individual strategy, optimized by erythropoietin (EPO) and metabolic adjustment (ScvO2) | ||
| Medical condition: Heart failure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003648-31 | Sponsor Protocol Number: PKPDHM-001 | Start Date*: 2011-11-17 | |||||||||||
| Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
| Full Title: Pharmacokinetic-pharmacodynamic modeling of the postoperative pain sensation during patient-controlled analgesia with target-controlled infusion of Hydromorphone, taking into account the interactio... | |||||||||||||
| Medical condition: Pain therapy after elective cardiac surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-000540-14 | Sponsor Protocol Number: HIGHCARE | Start Date*: 2008-05-20 | |||||||||||
| Sponsor Name:ISTITUTO AUXOLOGICO ITALIANO | |||||||||||||
| Full Title: Role of the renin-angiotensin system in the cardiovascular, metabolic, neurologic and respiratory response to hypobaric hypoxia during sustained exposure to high altitude. | |||||||||||||
| Medical condition: This study is aimed at the investigation of adaptative physiological mechanisms at high altitude and not at the development of new therapeutic indications. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-003714-68 | Sponsor Protocol Number: 1744/2017 | Start Date*: 2017-11-15 | ||||||||||||||||
| Sponsor Name:Medical University of Vienna | ||||||||||||||||||
| Full Title: Effect of Supplemental Oxygen on Perioperative Brain Natriuretic Peptide Concentration in Cardiac Risk Patients - A prospective randomized clinical trial | ||||||||||||||||||
| Medical condition: Evaluation of the effect of 80% versus 30% supplemental oxygen administration during major abdominal surgery on postoperative brain natriuretic peptide concentration. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: AT (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2015-003036-12 | Sponsor Protocol Number: IFX-1-P2.2 | Start Date*: 2016-04-22 | ||||||||||||||||
| Sponsor Name:InflaRx GmbH | ||||||||||||||||||
| Full Title: A phase II randomized, placebo-controlled, double-blind, dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamic dose response relationship of IFX-1 in patients undergoing co... | ||||||||||||||||||
| Medical condition: Prevention of organ dysfunction induced by inflammatory response after complex cardiac surgery | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2014-004295-28 | Sponsor Protocol Number: STER-AMVR-01 | Start Date*: 2014-11-14 | |||||||||||
| Sponsor Name:Oulu University Hospital, Department of Anaesthesia | |||||||||||||
| Full Title: Postoperative pain management after heart valve surgery using parasternal block and PCA Oxycodone | |||||||||||||
| Medical condition: Mitral or aortic valve disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-003557-24 | Sponsor Protocol Number: 400-12-004 | Start Date*: 2014-04-02 |
| Sponsor Name:Ethicon Inc | ||
| Full Title: A Prospective, Randomised, Controlled, Study Evaluating the Safety and Effectiveness of EVARREST® Sealant Matrix in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During O... | ||
| Medical condition: Mild or moderate hepatic parenchyma or soft tissue bleeding during open, abdominal, retroperitoneal, pelvic and thoracic (non-cardiac) surgery | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.